KalVista Pharmaceuticals Inc (KALV)
9.33
+0.37
(+4.13%)
USD |
NASDAQ |
Nov 21, 16:00
9.33
0.00 (0.00%)
After-Hours: 20:00
KalVista Pharmaceuticals Max Drawdown (5Y): 95.42% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 95.42% |
| September 30, 2024 | 95.42% |
| August 31, 2024 | 95.42% |
| July 31, 2024 | 95.42% |
| June 30, 2024 | 95.42% |
| May 31, 2024 | 95.42% |
| April 30, 2024 | 95.42% |
| March 31, 2024 | 95.42% |
| February 29, 2024 | 95.42% |
| January 31, 2024 | 95.42% |
| December 31, 2023 | 95.42% |
| November 30, 2023 | 95.42% |
| October 31, 2023 | 95.42% |
| September 30, 2023 | 95.42% |
| August 31, 2023 | 95.42% |
| July 31, 2023 | 95.42% |
| June 30, 2023 | 95.42% |
| May 31, 2023 | 95.42% |
| April 30, 2023 | 95.42% |
| March 31, 2023 | 95.42% |
| February 28, 2023 | 95.42% |
| January 31, 2023 | 95.42% |
| December 31, 2022 | 95.42% |
| November 30, 2022 | 95.42% |
| October 31, 2022 | 95.42% |
| Date | Value |
|---|---|
| September 30, 2022 | 95.42% |
| August 31, 2022 | 95.42% |
| July 31, 2022 | 95.42% |
| June 30, 2022 | 95.42% |
| May 31, 2022 | 95.42% |
| April 30, 2022 | 95.42% |
| March 31, 2022 | 95.42% |
| February 28, 2022 | 95.42% |
| January 31, 2022 | 95.42% |
| December 31, 2021 | 95.42% |
| November 30, 2021 | 95.42% |
| October 31, 2021 | 95.42% |
| September 30, 2021 | 95.42% |
| August 31, 2021 | 95.42% |
| July 31, 2021 | 95.42% |
| June 30, 2021 | 95.42% |
| May 31, 2021 | 95.42% |
| April 30, 2021 | 95.42% |
| March 31, 2021 | 95.42% |
| February 28, 2021 | 95.42% |
| January 31, 2021 | 95.42% |
| December 31, 2020 | 95.42% |
| November 30, 2020 | 95.42% |
| October 31, 2020 | 95.42% |
| September 30, 2020 | 95.42% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
95.39%
Minimum
Nov 2019
95.42%
Maximum
Mar 2020
95.42%
Average
95.42%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Nuwellis Inc | 100.00% |
| Perspective Therapeutics Inc | 91.70% |
| Electromed Inc | 55.84% |
| Xtant Medical Holdings Inc | 98.74% |
| Myomo Inc | 99.75% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -14.81 |
| Beta (5Y) | 0.9158 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 88.89% |
| Historical Sharpe Ratio (5Y) | -0.0337 |
| Historical Sortino (5Y) | -0.0596 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.16% |